Boca Raton, FL –As the novel coronavirus (COVID-19) continues to be breaking news with the national and international media, as well as becoming somewhat political with economic implications, it’s important to note that this is a lung and respiratory health issue facing the world’s population. Dry salt therapy (aka halotherapy, ‘halo’ is Greek for salt) has been researched for the past few decades around the world with very positive results in relieving upper and lower respiratory conditions. In many countries, it is an approved therapeutic treatment covered by health providers.
The Salt Therapy Association (STA) has over 1600+ members and there are approximately 1250+ facilities throughout the United States that provide dry salt therapy. In 2014, the Salt Therapy Association was formed by an international group of the most prominent industry experts, leaders, influencers and medical professionals, including Founding Director Dr. Daniel T. Layish, MD, a 20-year veteran pulmonologist and Board Certified in Pulmonary Disease.
According to Dr. Layish, “It is too early to tell what impact halotherapy may have with this strain of the coronavirus, however, this coronavirus does affect the respiratory and lung system and dry salt therapy has shown to provide symptomatic benefit such as in a clinical study we conducted that focused on patients with cystic fibrosis.” A strong advocate for this complementary therapy, Dr. Layish often recommends his patients to the local Salt Room in Orlando, Florida.